Source:http://linkedlifedata.com/resource/pubmed/id/15734959
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-2-28
|
pubmed:abstractText |
The purpose of this study was to compare the detection of human papillomavirus (HPV) DNA with detection of mRNA. The study included 4,136 women >30 years of age. E6/E7 mRNA expression from the carcinogenic HPV types 16, 18, 31, 33, and 45 was detected by the PreTect HPV-Proofer assay, whereas the presence of HPV DNA was detected by Gp5+/6+ consensus PCR followed by type-specific PCR. A total of 4.0% had an abnormal cytologic diagnosis, 3.0% were positive by PreTect HPV-Proofer, 4.4% by type-specific PCR, and 10.4% by consensus PCR. For detection of HPV in high-grade squamous intraepithelial lesion (HSIL), no significant difference was observed between PreTect HPV-Proofer and consensus PCR. For women with a cytologic normal, atypical squamous cell of uncertain significance, and low-grade SIL diagnosis, the detection rate of HPV was significantly higher by Gp5+/6+ consensus PCR (P < 0.005) than by PreTect HPV-Proofer. Histology confirmed 14 of 23 cytologic HSIL as cervical intraepithelial neoplasia grade >2. Of these women, PreTect HPV-Proofer and type-specific PCR detected 12, whereas consensus PCR detected 13. In conclusion, for HSIL, detection of E6/E7 transcripts from HPV types 16, 18, 31, 33, and 45 are present to the same degree as DNA detected by consensus PCR. Equally important, only a small proportion of the HPV DNA-positive women with a normal, atypical squamous cell of uncertain significance or low-grade SIL diagnosis had a detectable mRNA expression. HPV E6/E7 mRNA detection by PreTect HPV-Proofer represents a new promising test as an adjunct to cytology.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1055-9965
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
367-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15734959-Adult,
pubmed-meshheading:15734959-Carcinoma, Squamous Cell,
pubmed-meshheading:15734959-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:15734959-Cross-Sectional Studies,
pubmed-meshheading:15734959-DNA, Viral,
pubmed-meshheading:15734959-Female,
pubmed-meshheading:15734959-Follow-Up Studies,
pubmed-meshheading:15734959-Humans,
pubmed-meshheading:15734959-Mass Screening,
pubmed-meshheading:15734959-Middle Aged,
pubmed-meshheading:15734959-Papillomaviridae,
pubmed-meshheading:15734959-Papillomavirus Infections,
pubmed-meshheading:15734959-Polymerase Chain Reaction,
pubmed-meshheading:15734959-RNA, Messenger,
pubmed-meshheading:15734959-RNA, Viral,
pubmed-meshheading:15734959-Uterine Cervical Neoplasms,
pubmed-meshheading:15734959-Vaginal Smears
|
pubmed:year |
2005
|
pubmed:articleTitle |
Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.
|
pubmed:affiliation |
Institute of Pathology, National University Hospital, Sognsveien 20, 0027 Oslo, Norway. t.e.f.molden@labmed.uio.no
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|